Search
InsiderInsights.com

Narachi Michael (1380022)

Narachi Michael has been a registered insider at 3 firms since 2006. As Chief Executive Officer at Orexigen Therapeutics, Inc., Narachi Michael last made a transaction on 7/17/2012. As a Director at Empire Insurance Co, Narachi Michael last made a transaction on 2/4/2014. As a Director at AMAG Pharmaceuticals, Inc., Narachi Michael last made a transaction on 5/25/2012.

Orexigen Therapeutics, Inc. (OREX, OREXQ)

Titles: PR,CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
3 33% -0% 4% 16 1 Year 3 100% -8% -5% 18
3 67% -2% -5% 27 9 Month 3 67% -9% -10% 30
3 100% -8% -9% 14 6 Month 3 100% -13% -14% 4
3 67% -4% -1% 18 3 Month 3 100% -11% -11% 15
3 67% -24% -33% 41 1 Month 3 100% -29% -37% 39
3 67% -7% -11% 18 1 Week 3 100% -12% -9% 24
Scorecards Updated 6/14/2023 09:29 AM EST Latest Transaction Date: 7/17/2012
Average days between Transaction and Entered Dates: 1

Celladon Corp (EIGR, CLDN)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% 103% -- -- 1 Year 1 0% -- -- --
1 100% 48% -- -- 9 Month 1 0% -- -- --
1 100% 46% -- -- 6 Month 1 0% -- -- --
1 100% 23% -- -- 3 Month 1 0% -- -- --
1 100% 46% -- -- 1 Month 1 0% -- -- --
1 0% -3% -- -- 1 Week 1 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/14/2023 09:29 AM EST Latest Transaction Date: 2/4/2014
Average days between Transaction and Entered Dates: 2

AMAG PHARMACEUTICALS INC. (AMAG)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 100% 50% 50% -- 1 Year 2 0% -- -- --
2 100% 15% 15% -- 9 Month 2 0% -- -- --
2 100% 5% 5% -- 6 Month 2 0% -- -- --
2 100% 5% 5% -- 3 Month 2 0% -- -- --
2 100% 6% 6% -- 1 Month 2 0% -- -- --
2 0% -2% -2% -- 1 Week 2 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/14/2023 09:29 AM EST Latest Transaction Date: 5/25/2012
Average days between Transaction and Entered Dates: 5
© 2024 InsiderInsights.com